Announce Date | 02/12/2025 |
EPS Normalized Actual | $-0.04 (Beat by $0.05) |
EPS GAAP Actual | $-0.04 (Beat by $0.05) |
Revenue Actual | $12086.3B |
Revenue Surprise | Beat by $12086300M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.06 |
EPS GAAP Estimate | $-0.06 |
Revenue Estimate | $0.0229B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2027 | 0.08 | 12.51 | 0.07869958 | 0.08130042 | 1 |
Mar 2026 | -0.18 | -5.56 | -0.18 | -0.18 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | -36550.5 | -36550.42 | 12086.3B | 100% | 12086279.5M |
FQ3 2024 (Sep 2024) | -318670 | -318669.73 | 11874.1B | 100% | 11874083.1M |
FQ2 2024 (Jun 2024) | -707283 | -707283 | 8931.52B | 100% | 8931499.73M |
FQ2 2021 (Jun 2021) | -0.0004 | -0.0004 | 0B | NAN% | 0M |
FQ4 2021 (Dec 2021) | -0.0082 | -0.0082 | 0B | NAN% | 0M |
FQ2 2022 (Jun 2022) | -0.0036 | -0.0036 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | 0 | 0.33 | 0.0100014B | 49.95% | -5.7M |
FQ4 2023 (Dec 2023) | -0.45 | -0.45 | 0.0156414B | 78.8% | 15.64M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
-0.06
Consensus Revenue Estimates
0.0229B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0.04 | -- | 0.04 | 0.04 | 1 |
FQ4 2026 (Dec 2026) | 0.02 | -- | 0.02 | 0.02 | 1 |
FQ3 2026 (Sep 2026) | 0.01 | -- | 0.01 | 0.01 | 1 |
FQ2 2026 (Jun 2026) | 0 | -- | 0 | 0 | 0 |
FQ1 2026 (Mar 2026) | -0.03 | -- | -0.03 | -0.03 | 0 |
FQ4 2025 (Dec 2025) | -0.05 | -73100900 | -0.05 | -0.05 | 0 |
FQ3 2025 (Sep 2025) | -0.05 | -637339900 | -0.05 | -0.05 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
FQ3 2026 (Sep 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ2 2026 (Jun 2026) | 0.02B | -- | 0.02B | 0.02B | 1 |
FQ1 2026 (Mar 2026) | 0.03B | -- | 0.03B | 0.03B | 0 |
FQ4 2025 (Dec 2025) | 0.03B | -43319971.68 | 0.03B | 0.03B | 0 |
FQ3 2025 (Sep 2025) | 0.03B | -47307071.31 | 0.03B | 0.03B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
1
Revenue # of in-lines
3
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | -0.08 | -36550.5 | -36550.42 | 100% |
FQ3 2024 (Sep 2024) | -0.27 | -318670 | -318669.73 | 100% |
FQ2 2024 (Jun 2024) | 0 | -707283 | -707283 | 100% |
FQ2 2021 (Jun 2021) | -0.0004 | -0.0004 | 100% | |
FQ4 2021 (Dec 2021) | -0.0082 | -0.0082 | 100% | |
FQ2 2022 (Jun 2022) | -0.0036 | -0.0036 | 100% | |
FQ1 2024 (Mar 2024) | -0.33 | 0 | 0.33 | INF% |
FQ4 2023 (Dec 2023) | -0.45 | -0.45 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0.02B | $12086.3B | $12086279.5M | 100% |
FQ3 2024 (Sep 2024) | $0.02B | $11874.1B | $11874083.1M | 100% |
FQ2 2024 (Jun 2024) | $0.02B | $8931.52B | $8931499.73M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0B | $0M | NAN% |
FQ4 2021 (Dec 2021) | $0B | $0B | $0M | NAN% |
FQ2 2022 (Jun 2022) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0.02B | $0.01B | $-5.7M | -56.98% |
FQ4 2023 (Dec 2023) | $0B | $0.02B | $15.64M | 100% |